Metabolomic Abnormalities in Serum from Untreated and Treated Dogs with Hyper- and Hypoadrenocorticism

Loading...
Thumbnail Image
Authors
Imbery, Carolin Anna
Dieterle, Frank
Ottka, Claudia
Weber, Corinna
Müller, Elisabeth
Lohi, Hannes
Giger, Urs
Author (Corporation)
Publication date
09.04.2022
Typ of student thesis
Course of study
Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Metabolites
Special issue
DOI of the original publication
Link
Series
Series number
Volume
12
Issue / Number
4
Pages / Duration
Patent number
Publisher / Publishing institution
MDPI
Place of publication / Event location
Basel
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
The adrenal glands play a major role in metabolic processes, and both excess and insufficient serum cortisol concentrations can lead to serious metabolic consequences. Hyper- and hypoadrenocorticism represent a diagnostic and therapeutic challenge. Serum samples from dogs with untreated hyperadrenocorticism (n = 27), hyperadrenocorticism undergoing treatment (n = 28), as well as with untreated (n = 35) and treated hypoadrenocorticism (n = 23) were analyzed and compared to apparently healthy dogs (n = 40). A validated targeted proton nuclear magnetic resonance (1H NMR) platform was used to quantify 123 parameters. Principal component analysis separated the untreated endocrinopathies. The serum samples of dogs with untreated endocrinopathies showed various metabolic abnormalities with often contrasting results particularly in serum concentrations of fatty acids, and high- and low-density lipoproteins and their constituents, which were predominantly increased in hyperadrenocorticism and decreased in hypoadrenocorticism, while amino acid concentrations changed in various directions. Many observed serum metabolic abnormalities tended to normalize with medical treatment, but normalization was incomplete when compared to levels in apparently healthy dogs. Application of machine learning models based on the metabolomics data showed good classification, with misclassifications primarily observed in treated groups. Characterization of metabolic changes enhances our understanding of these endocrinopathies. Further assessment of the recognized incomplete reversal of metabolic alterations during medical treatment may improve disease management.
Keywords
Cushing’s syndrome, Morbus Addison, canine, nuclear magnetic resonance, laboratory diagnostics, endocrinopathy
Subject (DDC)
Project
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
2218-1989
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Gold
License
'https://creativecommons.org/licenses/by/4.0/'
Citation
IMBERY, Carolin Anna, Frank DIETERLE, Claudia OTTKA, Corinna WEBER, Elisabeth MÜLLER, Hannes LOHI, Urs GIGER und Götz SCHLOTTERBECK, 2022. Metabolomic Abnormalities in Serum from Untreated and Treated Dogs with Hyper- and Hypoadrenocorticism. Metabolites. 9 April 2022. Bd. 12, Nr. 4. DOI 10.3390/metabo12040339. Verfügbar unter: https://doi.org/10.26041/fhnw-4308